Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

June 13, 2017 | REGULATORY

Immunovia´s biomarker signature for the diagnosis of pancreatic cancer now patented in Japan

Read press release
April 25, 2017 | REGULATORY

Immunovia Stämmokommuniké

Read press release
April 20, 2017 | REGULATORY

Immunovia Interim report, January-March 2017

Read press release
April 19, 2017

Immunovia inbjuder till telefonkonferens den 20 april 2017

Read press release
March 24, 2017 | REGULATORY

IMMUNOVIA AB KALLAR TILL ÅRSSTÄMMA OCH PUBLICERAR ÅRSREDOVISNING FÖR RÄKENSKAPSÅRET 2016

Read press release
March 7, 2017 | REGULATORY

Final data from major Swedish study confirms that IMMray™ biomarker microarray differentiates SLE from other autoimmune diseases with 96% accuracy

Read press release
February 22, 2017 | REGULATORY

Immunovia tillkännager genomförd blocktransaktion i bolagets aktier

Read press release
February 15, 2017 | REGULATORY

Immunovia Financial Statement 2016

Read press release
February 14, 2017 | REGULATORY

Immunovia inbjuder till telefonkonferens den 15 februari 2017

Read press release
February 13, 2017 | REGULATORY

Immunovia presenterar vid Vator Securities Unicorn Summit

Read press release
January 16, 2017 | REGULATORY

University of Michigan Pancreatic Cancer Center new partner in Immunovia’s global PANFAM-1 prospective validation study

Read press release
January 13, 2017

Immunovia bjuder in till telefonkonferens tisdag 17/1 kl 16:00

Read press release
1 21 22 23 24 25 27